Latest News

ESC Scientific Statement: Extreme Heat Poses Significant Cardiovascular Risk
Written by: Radcliffe Cardiology
ESC Scientific Statement: Extreme Heat Poses Significant Cardiovascular Risk
Live Zoster Vaccination Linked to Reduced Cardiovascular Event Risk
Written by: Radcliffe Cardiology
Live Zoster Vaccination Linked to Reduced Cardiovascular Event Risk
Vutrisiran Attenuates Cardiac Decline in ATTR-CM, HELIOS-B Analysis Shows
Written by: Radcliffe Cardiology
Vutrisiran Attenuates Cardiac Decline in ATTR-CM, HELIOS-B Analysis Shows
ICOS-CORE Whitepaper Calls for Rigorous Evidence to Support Cardio-oncology Rehabilitation
Written by: Radcliffe Cardiology
ICOS-CORE Whitepaper Calls for Rigorous Evidence to Support Cardio-oncology Rehabilitation
Tirzepatide Benefits in HFpEF Consistent Across Obesity Levels, SUMMIT Analysis Shows
Written by: Radcliffe CVRM
Tirzepatide Benefits in HFpEF Consistent Across Obesity Levels, SUMMIT Analysis Shows
Written by: Radcliffe CVRM
Increased Systolic Blood Pressure Variability Over Time Linked to Higher Risk of CVD, CKD, and Death
Heart Rate Lowering Benefits are Context-Dependent, Meta-Analysis Finds
Written by: Radcliffe Cardiology
Heart Rate Lowering Benefits are Context-Dependent, Meta-Analysis Finds
ESC Congress 2025 Releases its Late-Breaking Scientific Programme
Written by: ESC Congress 2025 Scientific Programme
ESC Congress 2025 Releases its Late-Breaking Scientific Programme
Hot Line Sessions Revealed for ESC Congress 2025
Written by: ESC Congress 2025 Scientific Programme
Hot Line Sessions Revealed for ESC Congress 2025
Intravenous Ferric Carboxymaltose in FAIR-HF2 Trial Shows No Significant Reduction in Heart Failure Events but Improves Quality of Life
Written by: Radcliffe Cardiology
Intravenous Ferric Carboxymaltose in FAIR-HF2 Trial Shows No Significant Reduction in Heart Failure…

External news

Written by: Academic - advance access - HF
Beyond phenogroups: towards a continuous biology of HFpEF
Written by: Academic - advance access - HF
Biochemical triple testing to exclude monoclonal gammopathy for non-biopsy diagnosis of transthyretin amyloid cardiomyopathy
Written by: Academic - advance access - HF
Exercise cardiac magnetic resonance biventricular volumetric reserve in heart failure with preserved ejection fraction
Written by: Academic - open access - HF
Hemodynamic Changes in Response to GLP-1 Treatment in ICD and CRT Patients: Insights From HeartLogic Sensor Data
Written by: Academic - advance access - HF
Hemodynamic Changes in Response to GLP-1 Treatment in ICD and CRT Patients: Insights From HeartLogic Sensor Data
Written by: Academic - advance access - HF
The spectrum of steatotic liver disease (SLD) in cardiology – time to screen for coexisting liver disease
Written by: Academic - advance access - HF
Letter regarding the article ‘Impact of contemporary guideline-directed medical therapy on secondary mitral and tricuspid regurgitation in heart failure with reduced ejection fraction’
Written by: Academic - advance access - HF
Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA
Written by: Academic - open access - HF
Dyssynchronous heart failure: mitochondrial distribution and functions mirror regional workload and energy demand in a large-animal model of ventricular desynchronization
Written by: Academic - advance access - HF
Dyssynchronous heart failure: mitochondrial distribution and functions mirror regional workload and energy demand in a large-animal model of ventricular desynchronization